Stocks Hitting 52-Week Highs

shares touched a new 52-week high of $57.58. Nevro reported a Q1 loss of $0.57 per share on revenue of $9.662 million. The company received the FDA approval for its Senza spinal cord stimulation system.

shares gained 1.25 percent to reach a new 52-week high of $58.93. Avery Dennison shares have jumped 18.87 percent over the past 52 weeks, while the S&P 500 index has gained 11.57 percent in the same period.

shares reached a new 52-week high of $6.47. NetSol Tech reported Q1 adjusted earnings of $0.09 per share on revenue of $13.1 million.

shares touched a new 52-week high of $20.49. Momenta Pharmaceuticals' trailing-twelve-month revenue is $52.25 million.